96 related articles for article (PubMed ID: 11301910)
1. [ACE inhibitors versus AR II antagonists. Their role in arterial hypertension].
Carmona JP
Rev Port Cardiol; 2000 Dec; 19 Suppl 2():II43-9. PubMed ID: 11301910
[TBL] [Abstract][Full Text] [Related]
2. [The therapy of arterial hypertension: a comparison between ACE inhibitors and angiotensin-II-receptor antagonists].
Rossi F; Mangrella M; Paternò E; Imperatore F; Capristo M; Imperatore C; Guarino A
Clin Ter; 1996 Oct; 147(10):475-88. PubMed ID: 9264900
[TBL] [Abstract][Full Text] [Related]
3. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
Aulakh GK; Sodhi RK; Singh M
Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
5. Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology.
Chiu AG; Krowiak EJ; Deeb ZE
Laryngoscope; 2001 Oct; 111(10):1729-31. PubMed ID: 11801934
[TBL] [Abstract][Full Text] [Related]
6. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
Carnovali M
Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
[TBL] [Abstract][Full Text] [Related]
7. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].
Andersen RS; Christensen S
Ugeskr Laeger; 2001 Dec; 163(50):7036-9. PubMed ID: 11794033
[TBL] [Abstract][Full Text] [Related]
8. [Angiotensin II type-1-receptor antagonists from the viewpoint of nephrology].
Hauser AC; Hörl WH
Wien Med Wochenschr; 2001; 151(7-8):160-4. PubMed ID: 11450164
[TBL] [Abstract][Full Text] [Related]
9. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
10. [Comparison between AngII receptor antagonist and ACE inhibitor].
Fujimi K; Urata H
Nihon Rinsho; 2001 May; 59(5):999-1003. PubMed ID: 11392005
[TBL] [Abstract][Full Text] [Related]
11. Benefits of angiotensin converting enzyme inhibition and angiotensin II receptor antagonists in hypertension.
Conlin PR
J Med Liban; 2000; 48(6):382-6. PubMed ID: 11503531
[TBL] [Abstract][Full Text] [Related]
12. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
Burnier M
Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
[TBL] [Abstract][Full Text] [Related]
13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
14. [Rationale for the use of renin-angiotensin inhibitors in the treatment of arterial hypertension and correlated organ damage].
Mammarella A; Paoletti V; De Matteis A; Di Franco M; Cavina G; Paradiso M
Clin Ter; 2002; 153(1):45-9. PubMed ID: 11963634
[TBL] [Abstract][Full Text] [Related]
15. [Angiotensin-converting enzyme inhibitors and/or angiotensin II receptors antagonists in the treatment of arterial hypertension].
Silance PG
Rev Med Brux; 2003 Sep; 24(4):A253-6. PubMed ID: 14606289
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Crook ED; Preddie DC
Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
[TBL] [Abstract][Full Text] [Related]
18. [Converting enzyme inhibitors or AT1 receptor blockers].
Trevethan Cravioto S
Arch Cardiol Mex; 2001; 71 Suppl 1():S171-6. PubMed ID: 11565329
[TBL] [Abstract][Full Text] [Related]
19. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
Rajzer M; Kawecka-Jaszcz K; Wojciechowska W
Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
[TBL] [Abstract][Full Text] [Related]
20. RAS inhibition in hypertension.
Ibrahim MM
J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
